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Cardiovascular disease (CVD) risk factors, such as increased body fat, dyslipidemia, and high 
sensitivity C-reactive protein (CRP) levels are intensified in postmenopausal women.  CRP has 
been reported as an independent indicator of risk for cardiovascular events.  CRP is affected by 
multiple factors such as age, race, body mass index (BMI), and physical activity level.  The 
purpose of this study was to compare the effects of an exercise intervention on traditional (BMI, 
percent body fat, waist circumference, physical activity level) and non-traditional (CRP) risk 
factors for cardiovascular disease to a dietary intervention program in sedentary, postmenopausal 
women.  Twenty apparently healthy postmenopausal women were randomly assigned to a diet 
intervention group (DI) or an exercise intervention group (EXI) for a period of 9 weeks.  DI 
participants reported once a week for a body weight measurement and EXI participants were 
asked to attend 3 exercise sessions per week that were 45-55 minute sessions (cardiovascular and 
resistance training exercises).  There were no significant effects of time or treatment intervention, 
or a time x treatment interaction on CRP levels (p=0.077, p<0.05).  However, there was a 
significant change (-4.45 kg) in body weight (p=0.000, p< 0.05) and (-1.1 kg) change in fat free 
mass (p=0.041, p<0.05) in the DI group.  Body weight, FFM, and waist circumference all 
decreased significantly in the DI group; however, decreases in these variables did not appear to 
precipitate significant changes in CRP.  It is possible that a greater degree of weight loss (over a 
longer duration) may be necessary to decrease CRP levels.  There was no significance between 
EXI and dependant variables, including CRP, also suggesting that greater intensity or longer 










Cardiovascular disease (CVD) is the major cause of death among the U.S. population.
8, 16, 
33
 With aging, the risk of CVD proportionally increases; however, women are affected by CVD 
10 years after men.
25,33
  Clinical diagnosis for CVD in women is more challenging than men 
because women do not present typical signs of chest pain or ischemia.  CVD death rates are 34% 
higher in black women than white women due to the higher prevalence of CVD risk factors, such 
as diabetes and obesity.
23,33
   Risk factors for CVD in women are smoking (leading cause), 
hypertension, dyslipidemia, diabetes mellitus, obesity, sedentary lifestyle, and menopause.
6, 25, 33, 
44, 46
  Hypertension, dyslipidemia, and obesity are risk factors for both men and women; 60% of 
white women and 79% of black women over the age of 45 are classified as hypertensive (systolic 
blood pressure ≥140 mm Hg or diastolic blood pressure ≥ 90 mm Hg).
33
  Regarding increased 
total cholesterol, 55% of women over 55 years old are classified as high (≥ 240 mg/dL).  Low 
HDL level is a stronger CVD predictor for women than men; as, a 1% increase in HDL is 
associated with 3-5% decrease in risk for women.
33, 46
  Obesity, especially increased abdominal 
adiposity, is a risk factor for CVD in women.  The prevalence of obesity has increased over the 
past decade and currently one out of three women is classified as obese.  Obesity is a parallel 
factor to sedentary lifestyle, and studies have shown that moderate physical activity reduces the 
risk of CVD by 50% in women.  Schenck
46
 reported in 2009 that 30% of women are overweight 




Postmenopausal women experience similar risk factors as men; however, certain CVD 
risk factors are intensified in postmenopausal women.
44, 46
  Redistribution of fat from gynoid to 
android pattern, increased body fat, increased blood pressure, and dyslipidemia amplify CVD 
risk.
4, 41 
 Menopause decreases the estrogen levels and increases testosterone levels in 
postmenopausal women, negatively affecting cardiovascular functions and metabolism resulting 
2 
 
in an increase risk for CVD event, such as dyslipidemia resulting from increased testosterone.
 41
  
A 2-fold increase for CVD occurs with low sex hormone binding globulin or high free androgen 
index value.
41
   
In addition to the serum cholesterol risk factors, abnormal lipoprotein, C-reactive protein 
(CRP) and interleukin-6 levels are known risk factors for CVD in women.
3, 13, 15, 39, 46
  
Inflammation markers have been determined to have a significant role in the development of 
atherosclerosis and CVD, but the relationship between the inflammation process and CVD is 
complex.
4, 16, 22
  In response to tissue inflammation, CRP is stimulated by interleukin-6, 
interleukin-1, and tumor neurosis factor.
22
  This response occurs when activated immune cells in 
the plaque produce inflammatory cytokines, stimulating the production of substantial amounts of 
interleukin-6.  Interleukin-6, in response, stimulates the production of large amounts of acute-
phase reactants (C-reactive protein, serum amyloid A, and fibrinogen) in the liver.  Plasma 
concentration of CRP can increase 100-fold after acute inflammatory stimulus.
5, 11, 42
  According 
to Hansson,
16
 cytokines have important biologic effects at all steps; however, their amplification 
at each step of the cascade makes the measurement of downstream mediators such as CRP 
particularly useful for clinical diagnosis. 
CRP is an inflammatory marker that has been investigated regarding its influence on an 
individual’s risk for CVD.  Several investigators have suggested that CRP levels reflect the 
inflammation status, which is related to the severity of atherosclerosis.
5, 11, 22, 42
  CRP is an 
independent indicator of risk for stroke, peripheral vascular disease, and vascular death among 
healthy men and women without any known vascular diseases and is a stronger predictor for CV 
events compared to LDL-C levels.
 5, 11, 42, 43
  Currently practitioners consider CRP value of less 
than 2 mg/L as healthy, and individuals who have CRP levels of 5mg/L or greater may be at an 
increased risk for a cardiac event within six months.
22, 26
  
CRP is affected by multiple factors such as age, race, body mass index (BMI), and 
physical activity level.
1, 3, 4, 9, 13, 14, 17, 18, 22, 28, 49, 52, 53
  CRP levels have been shown to increase with 
3 
 
age; therefore, BMI and physical activity level are needed to counteract the natural rise in CRP 
levels.
22, 28
  CRP is highly correlated with BMI and several studies have reported a strong 
correlation between total fat mass and visceral fat and CRP.






have  reported that subjects with a BMI >30 kg/m
2
 had elevated CRP levels and CRP levels were 
found to be 270% higher in individuals in the top quintile of BMI compared to those in the 
bottom quintile.  In addition to BMI, a direct relationship between elevated CRP levels and 
abdominal fat distribution via waist circumference measurement has been documented.
17, 18, 52
  A 
waist circumference greater than 88 centimeters can be associated with a higher BMI and higher 
risk for CVD due to increased visceral fat and increase in serum resistin.
18, 51
  Finally, increased 
physical activity levels are related to decreased fat and lower BMI resulting in decreased CPR 
levels.
1, 3, 14, 29, 49
     
A review of current literature indicates that there is an inverse relationship between 
physical activity and CRP levels.  Specifically, investigators have observed the lowest CRP levels 
in individuals with the highest activity levels.
1,3,10,14
  Physical activity is associated with a lower 
risk of subsequent CVD events; however, physical activity in young adulthood was not a 
predictor of CVD risk several decades later.
10 
 There is an inverse relationship between physical 
activity during middle age and CVD risk; therefore, it is necessary to maintain physical activity 
levels with aging to minimize a cardiovascular event.  Along with an inverse relationship between 
physical activity level and CRP levels being reported, there is an inverse association between 
intensity and/or frequency of exercise with CRP levels.  CRP levels decrease with more vigorous 
exercise or more frequent exercise.
1, 3, 49
  Cross sectional studies used questionnaires to determine 
participants’ physical activity frequency and intensity, and the 6-minute walk test, treadmill 
VO2max test, and cycle ergometry VO2max test were used to determine physical activity level.
1, 2, 3, 9, 
14, 29, 49 
 Higher VO2max  measurements were associated with lower CRP levels.
3,29
  The dose-
response relationship utilizes frequency and/or intensity of physical activity to determine the 





Multiple studies have shown that with weight loss and exercise, CRP levels decrease in 
proportion to weight loss.
30, 38, 40, 45
  Increased physical activity promotes decreased weight, body 
fat percentage, adipose tissue, and BMI resulting in decreased CRP levels.
45
  Cross sectional 
studies used questionnaires to determine participants’ physical activity frequency and intensity or 
participants’ complete a submaximal treadmill test to determine VO2max.
3, 31, 40
  Intervention 
studies consisting of aerobic activity 3 days/week through group exercise classes, treadmill, or 
cycling for 30-60 minutes at 60% VO2max or between 60-80% peak heart rate resulted in a 
decrease in body weight, percentage body fat, fat mass, fat free mass, visceral adipose tissue, and 




   
The consensus of currently published studies indicates that CRP will decrease as a result 
of weight loss that is achieved through dietary changes.  Dietary interventions that have produced 
weight loss and decreased CRP values have been as short of one month and as long as 18 months 
in duration.  The majority of diet interventions reviewed consisted of a hypocaloric diet for a 
period of 12 weeks with obese women as the study population.
10, 14, 35, 36, 49
  Previous studies have 
solely investigated changes of CRP levels resulting from weight loss through dietary alterations 
or weight loss through exercise.  It is unknown if exercise without weight loss alone has an effect 
on CRP levels in sedentary, postmenopausal women.  The purpose of this study was to compare 
the effects of an exercise intervention versus a dietary intervention on traditional (BMI, percent 
body fat, waist circumference, physical activity level) and non-traditional (CRP) risk factors for 




Review of Literature 
Increased CRP levels have been reported as an independent predictor for CVD.
54
  Risk 
factors that affect CRP are age, waist circumference, BMI, race, cholesterol, blood pressure, and 
physical activity level.
4, 13, 23, 25, 39
  Studies have been conducted on the obese, postmenopausal 
population and older men and women to determine if weight loss through diet, physical activity, 
and/or physical activity with weight loss affects CRP levels.  Weight loss through low calorie diet 
has been shown to reduce CRP levels in obese, postmenopausal women since the in CRP levels is 
primarily associated with loss in fat mass during weight loss.
50
  Also, physical activity has been 
associated with decreased CRP levels and reduced risk of CVD.  There is an inverse relationship 
between activity level and CVD risk and CRP level; as activity levels increase, CRP levels 
decrease in both genders.
3, 10, 49
  Along with decreased inflammatory markers, decreased weight, 
body fat percentage, adipose tissue, and BMI result from increased physical activity.
8, 45
  
Lifestyles changes, especially physical activity and diet, can promote significant improvements of 
CVD risk factors, such as decreased CRP levels.   
Table 1: Risk Factors for Cardiovascular Disease.  
Article Problem/Question 
Studied 




women: myths and 
reality (Lewis, 2002). 
Focus on 
epidemiology and 
impact of CVD on 
women and review 
risk factors.  
Review paper. Review paper. Positive lifestyle 
(physical activity, 
weight control, 
healthy diet, and  
smoking cessation) 
reduce the 
prevalence of CVD. 
Menopause and 
cardiovascular 
disease: the evidence 
(Romano, 2007). 
To discuss 
menopause of a risk 
factor for CVD. 
Review paper. Review paper. Menopause is 
associated with a 
significant increase 




Risk factor for 
cardiovascular 
disease in women 
(Schenck-
Gustafsson, 2009). 
To discuss CVD risk 
factors in women. 
Review paper. Review paper. CVD is presented 
later in life for 
women and are more 
likely to be suffer 
with co-morbidities, 







Participants Procedures Findings 
Inflammatory 
markers and the risk 
of coronary heart 
disease in men and 
women (Pai, 2004). 
To investigate 
inflammatory markers 
as predictors of CVD. 
239 women and 265 
men. 
Blood samples were 
collected. 
Elevated levels of 
inflammatory 
makers, especially 
CRP, indicate risk of 
CVD. 
Sex hormone levels 





To examine the 
relationship of plasma 
androgens and 







Low dose of aspirin 
and vitamin E were 
administered; blood 
samples were 
collected to analyze 
estradiol levels. 
Low sex hormone 
binging globulin or 
high free androgen 
index is associated 
with increased risk 










To determine which 
fat-distribution 
variables (arm fat, leg 
fat, trunk fat, 
intraabdominal 
adipose fat, or 
subcutaneous adipose 
fat) have independent 
relations with CVD 
risk. 




(17-77 years old). 
Cross-sectional 
design that analyzed 
body fat via CT 
(abdominal), UWW 
(bone density), 
DEXA (total body), 
height and weight 
were measured to 
nearest 0.5cm.  
Blood sample (after 
12 hour fast) to 
collect lipid 




adipose fat and trunk 
fat were positively 
related to CVD risk 
factors. 






To investigate to 
relationship between 
the degree of obesity 
and the incidence of 
CVD in men and 
women. 
5209 participants 
(2252 men and  2818 
women); 28-62 years 
old. 
Height and weight 




blood glucose, and 
smoking status were 
all measured. 
The degree of 
obesity in men and 
women is an 
important long term 






obesity, and oral 
contraceptive use in 
young adults 
(Williams, 2004). 
To determine the 
relationship between 
levels of CRP, CV 
risk factors, and oral 
contraceptive. 
822 men and 












CRP and obesity as 
cofounding risk 
factors of CVD. 
Elevated C-reactive 
protein levels in 
overweight and obese 
adults (Visser, 1999). 
To test whether 
overweight and 
obesity are associated 
with inflammation as 
measured by CRP. 






samples collected to 
measure CRP. 
Higher BMI is 
associated with 
elevated CRP levels. 
Blood pressure, C-
reactive protein, and 
risk of future 
cardiovascular events 
(Blake, 2003). 
To determine the 
relationship between 
CRP in blood 
pressure in women 
and determine 
whether blood 
pressure is an 
independent 
determinant of CRP 
levels. 
15,215 women over 
45 years old. 
Blood samples were 
collected, blood 




pressure is a 
determinant of CRP 
levels; however BP 
and CRP were 
confirmed as risk 












among adult US 
women (Ford, 2004). 










There was an 
association between 
CRP and BMI, waist 
circumference, 
cholesterol, and 
blood pressure.  
Race and gender 
differences in C-
reactive protein 
levels (Khera, 2005). 
To determine whether 
there are race and 
gender differences in 
CRP levels. 
2,749 white and 
black men and 
women (age 30-65 
years old). 
Weight, heart rate, 
blood pressure, and 
BMI were measured. 
Blood samples were 
collected after an 
overnight fast. 
Black women have 
higher CRP levels 




reactive protein, and 
traditional 
cardiovascular risk 
factors in women 
(Bermudez, 2002). 
To determine the 
relationship of IL-6, 
CRP, and CVD risk 
factors in healthy 
women. 
340 postmenopausal 
women (mean age 
60). 
Cross-sectional 




analyzed for IL-6 
and CRP. 
Age, BMI, blood 
pressure smoking 
status, and HDL 
levels are associated 
with CRP levels.   
Physical activity and 
cardiovascular 
disease risk in 
middle-aged and 




activity during middle 
and late years alters 
the risk of CVD. 
2,363 female 





reported the number 
of hours spent 
walking flights of 
stairs climbed, city 
blocks walked, and 
sports participated 
weekly.  Body 
weight and BMI 




decrease   CVD risk 
by 33%.    Overall, 
there is no 
association of 
physical activity and 
CVD risk in women.  
The benefit of 
walking was found 
in lean women only 
(BMI < 23). 
 
There are multiple factors that have been shown to affect C-reactive protein (CRP) levels 
and/or risk of cardiovascular disease (CVD) in women.  CRP levels and CVD have a direct 
relationship given that increased CRP levels have been reported as an independent predictor for 
CVD.
54
  There are risk factors that affect CRP while in effect increase the risk of CVD, such as 
age, waist circumference, BMI, race, cholesterol, blood pressure, and physical activity level.
4, 13, 
23, 25, 39





 as women age and menopause occurs, there is a decrease in estrogen 
levels, decrease in sex hormone binding globulin and increase in free androgen index while 
augments the risk of CVD.  Modifiable risk factors, such as waist circumference, BMI, and 
physical activity level, affect the risk of CVD in men and women.  Distribution of fat alters from 
8 
 
gyniod to android placing more fat in the abdominal area as women age.  Williams
 54
 reported that 
an increase in intraabdominal adipose fat and trunk fat, measured by waist circumference, 
enhance the risk of CVD in women.  In addition to waist circumference, elevated BMI has is 
associated with elevated CRP levels and an independent predictor of CVD in both men and 
women.
4, 13, 20, 25, 39, 52, 54
  Regarding race, it has been shown that black women have increased BMI 
and CRP levels compared to white women, increasing their risk for CVD.
23
  Finally, elevated 
total serum cholesterol in women is associated with elevated CRP levels.  Total serum cholesterol 
is related to increased BMI and increased intraabdominal abdominal fat.
13
         
The literature was consistent when observing age, waist circumference, BMI, race, and 
cholesterol.  However, there are inconclusive research regarding blood pressure and physical 
activity level and their effects on CRP levels and/or CVD risk.  Literature has shown that within 
postmenopausal women, increased blood pressure, specifically systolic blood pressure 
measurement, increase risk for CVD risk, but there is controversy research if blood pressure is a 




 stated that elevated blood pressure is associated with 
elevated CRP levels, whereas Blake
6
 reported that there is inconclusive evidence that blood 
pressure is a determinant for CRP level.  Finally, physical activity and its effects on CRP levels 
will be discussed in for detail in Table 3, but as a risk factor for postmenopausal women, Lewis
25
 
reported 80% lower risk for a cardiovascular risk and decreased CPR level if moderate to 
vigorous activity was performed for 30 minutes most days of the week, while Sesso
47
 reported 
that light activity, such as walking, can reduce the CVD risk by 33% but the relationship was not 
significant enough to state that physical activity is associated to CVD.   
Table 2: Effects of C-Reactive Protein with Weight Loss through Diet 
Article Problem/Question 
Studied 
Participants Procedures Findings 
The effect of weight 
loss on C-reactive 
protein (Selvin, 
2007). 
To test the 
hypothesis that 
weight loss is 
directly related to a 
decline in CPR level. 
Review paper. A review of weight 
loss intervention 
studies that included 
lifestyle, diet and/or 
exercise 
interventions. 
A decline in CRP 
level is associated 
with weight loss by 








Participants Procedures Findings 
C-reactive protein 
and coronary artery 









IL-6 and/or CRP 
level. 
 
Review paper. Review paper. CRP is a predictor of 







Effects of a dietary 
portfolio of 
cholesterol-lowering 
foods vs lovastain on 
serum lipids and C-
reactive protein 
(Jenkins, 2003). 
To determine the 
dose-response 
relationship of nuts 
and their advantage in 




adults; 25 men and 
21 postmenopausal 
women. 
1 m. intervention; 
body weight was 
measured weekly 
and blood samples 
were obtained every 
2 weeks after a 12-
hr fast; 1 of 3 diets 
were assigned (very 
low in saturated fat, 
very low in 
saturated fat plus 
lovastatin, high in 
plant sterols). 
All diets resulted in 
a decrease in C-
reactive protein 
levels; however, the 






Effect of high-fiber 
diet vs a fiber-
supplemented diet on 
C-reactive protein 
level (King, 2007). 
To examine the 
reduction in 
inflammation from a 
diet supplemented 
with fiber compared 
to a diet naturally 
high in fiber. 
 
35 participants (28 






fiber DASH diet or 
fiber-supplemented 
diet; photographs 
were taken for 3 
days of each 3 week 
diet; weekly urine 
samples, weight 
measurement, and 
diet consulting.  
Both diets 
demonstrated a 
decrease in CRP 
levels, however, 
CRP decreased 
significantly in lean 
group but no 
significance in obese 
group. 
Relation between a 
deit with a high 
glycemic load and 
plasma concentration 
of high-sensitivity C-
reactive protein in 
middle-aged women 
(Liu, 2002). 
To examine whether a 
high dietary glycemic 
load was associated 









design; blood draw 





index load is 
significantly and 
positively associated 








in obese, healthy 
women (Heilbronn, 
2001) 
To determine the 
effects of dynamic 






12 wk intervention 
(every 4 weeks after 
a 12-hr fast); weight 
recorded and blood 
drawn. 
CRP was lowered in 
proportion to weight 
loss.  
Weight loss reduces 
C-reactive protein 




To examine the 
relations among body 
fat, fat distribution, 




14 m. intervention 
(blood was tested 
after 12-hr fast and 
3 days of 
standardized meals); 
1200 kcal/day. One 
















Participants Procedures Findings 
Diet-induced weight 
loss is associated 
with decreases in 
plasma serum 





composition in obese 
subjects (O’Brien, 
2005). 




weight loss on levels 
of CRP. 
41 obese women.  3 m. intervention; 
1200 kcal/day low-
fat diet (AHA step 
1) or very low-
carbohydrate diet; 
weight and blood 
samples were 
completed for 
baseline and at 3 
months. 
There was a greater 
reduction in CRP 
with the very low- 
carbohydrate diet 
compared to the low-
fat diet. 
Effect of an energy-
restricted, high-
protein, low-fat diet 
relative to a 
conventional high-
carbohydrate, low-




and markers of 
cardiovascular health 
in obese women 
(Noakes, 2005). 
To evaluate the 
effects of a diet with a 
high ratio of protein 
to carbohydrate 
during weight loss on 
body composition, 
CVD risk, nutritional 
status, and markers of 
bone turnover and 
renal function in 
overweight women. 
100 obese women.  12 wk intervention; 
5600 kJ diet of high-
protein or high-
carbohydrate; 
consultation with a 
dietian every 4 
weeks and 
completed a food 
intake log; fasting 
blood samples were 
obtained at baseline, 
wk 4,8, and 12; 
weight was 
measured every 14 
days (after fasting 
overnight). 
Hypocaloric high-





weight loss) benefits 
that are greater than 
the high-
carbohydrate diet.  
Long-term effects of 
high-protein, low-
carbohydrate diet on 
weight control and 
cardiovascular risk 




To compare long term 
compliance and 
effects of two low fat 
diets differing in 
carbohydrates to 
protein ratio on body 
composition and 
biomarkers of CVD 







males and 45 
females. 
68 wk intervention 
(12 wk of energy 
restriction, 4 wk of 
energy balance, 52 
wk without 
counseling);  body 
weight and blood 
drawn at baseline, 
wk 16, and wk 68. 
Two diets were 
distributed (standard 
protein intake or 
high protein intake). 
Both diets were 
equally as effective 
in weight loss and 





loss, exercise, and 
chronic 
inflammation in 
older, obese adults: a 
randomized 
controlled clinical 
trial (Nicklas, 2004). 
To determine the 
independent and 
combined effects of 
diet-induced weight 
loss and exercise on 
the markers of 
chronic inflammation. 
316 sedentary, 
overweight men and 
women (>60 years). 
18 m. intervention; 
diet-induced weight 
loss (decease by 
5%), exercise (3 
days/week for 1 
hour sessions), or 
diet and exercise; 




Weight loss via diet 
reduced overall 
inflammation.  
Exercise training did 













Participants Procedures Findings 
Effects of 
hypocaloric diet and 
exercise training on 
inflammation and 
adipocyte lipolysis in 
obese 
postmenopausal 
women (You, 2004). 
To determine whether 
a hypocaloric diet 
with and without 
exercise training is 








6 m. intervention; 
body weight was 
measured, food 
records and diet 
instruction to elicit 
0.5-1.0kg/wk were 
done weekly; diet 
and exercise group 
also walked 3d/wk 
at target heart rate. 
CRP decreased with 
diet and exercise but 
not diet alone, even 
though both groups 
lost similar amounts 
of weight and 
adipose tissue. 
 
C-reactive protein is a predictor of acute vascular events due to the stimulation of CRP by 
interleukin-6 (IL-6) during the inflammation process.
17
  Among the population of in obese, 
postmenopausal women, weight loss has been shown to reduce CRP levels.
34, 48, 50
  Tchernof 
50
 
reported that the reduction in CRP levels is primarily associated with loss in fat mass [adipose 
tissue] during weight loss.  There have been numerous studies conducted researching different 
types of weight loss regimes that have resulted in lower CRP levels from baseline levels.
7, 18, 21, 24, 
27, 34, 35, 36, 55   
There are discrepancies among studies regarding diet and exercise versus diet alone 





 CRP levels did not decrease with weight loss and fat loss [adipose 
tissue] through diet alone; however CRP levels did decrease with weight loss and fat loss 
[adipose tissue] through diet and exercise.
55
   
Table 3: Effects of C-Reactive Protein through Physical Activity 
Article Problem/Question 
Studied 




disease risk in 
women (Oguma, 
2004).  
To review and 
quantify the dose-
response relationship 
of physical activity in 
healthy women on 
CVD outcomes.  
Meta-analysis. Studies reviewed 
inclusion criteria was 
data on women, 
assessed physical 
activity, and provided 
information on 
relative risk of CVD. 
Walking 1hour/week 
was associated with 




reduced risk of CVD 





























several measures of 
physical performance 
in older persons aged 
70 to 79 years.  
 
880 men and 
women, 65 yr or 
older. 
Blood samples were 
collected (non-
fasting); physical 
function tests were 
performed (baseline 





Higher IL-6 and 
CRP levels in those 
less active; CRP was 
related to increased 
walking speed and 
grip strength; 
signature time and 
chair-rise ability 
were not associated 





and risk of coronary 
heart disease 
(Conroy, 2005). 




adulthood and middle 
age, and physical 
activity during each 
time period and CHD 
occurring in middle- 
aged or older. 
Cohort study of 
37,169 healthy U.S. 
female health 
professionals, age 45 
yr or older. 





health habits, and 
medical history; 
participated in the 
trial after a 3-month 
run-in phase; follow-
up surveys asking 
about treatment 
compliance, 
risk factors, and 
endpoints of interest 
were mailed every 6 
months during the 
first year and 
annually. 
Physical activity at 
study baseline 
was associated with 
a lower risk of 
subsequent CHD 
events; however, 
physical activity in 
young adulthood was 
not a predictor of 
CHD risk several 
decades later. There 








activity and markers 




To measure the 
association between 
self reported physical 
activity with several 
markers of 





(male and female); 
2,501 diagnosed 
with clinical CVD 
and 3,837 did not 
have CVD. 
At baseline, medical 
history, medication, 
physical activity 






obtained 3 yr later. 
Physical activity 
level is associated 
with significantly 
lower levels of CRP, 
independent of 








and older US adults 
(Abramson, 2002). 
To examine the 
association of 
physical activity with 
3 markers of 
inflammation in a 
representative sample 




healthy US men and 
women 40 yr and 
older. 
Cross sectional study; 




behaviors; stage II, 
conducted within 4 
wks of stage I. 
A higher frequency 
of physical activity 
was associated with 
lower CRP levels. 
Low cardiovascular 
fitness is associated 
with elevated C-
reactive protein 
levels in women 





markers of CVD in 
women with type 2 
diabetes. 
28 women with type 
2 diabetes but absent 
of CVD events with 
low or average 
cardiorespiratory 
fitness levels.  
Cross sectional study. 
Physical examination 
and cycle ergometry 
test were performed 
to determine 
VO2max.  Blood 
samples were 
collected after an 
overnight fast along 
with an EKG. 
Low 
cardiorespiratory 
fitness is associated 












markers in older 
adults: Findings 
from the health, 
aging, and body 
composition study 
(Colbert, 2004). 
To examine the 
association between 
physical activity and 
inflammatory 
markers. 
3,075 black and 
white men and 
women (70-79 years 
old). 
Cross sectional study. 
Questionnaires 
determines physical 






markers are lower in 
older adults with 
higher levels of 
exercise. 
Effect of physical 
activity on serum C-
reactive protein 
(Albert, 2004).  
To examine the 
association between 
physical activity and 
CRP levels. 
1.732 men and 1.101 
women. 
Cross sectional study. 
Blood samples to 
evaluate CRP and 
lipids; data on age, 
smoking status, and 
diabetic status; 
physical activity level 
was self reported. 
There is an inverse 
relationship between 
physical activity and 
inflammatory 
biomarkers. 
C-reactive protein is 




To examine the 
relationship between 
physical fitness and 






Cross sectional study 
where body mass 
index was calculated, 
blood samples were 
collected after a 12 hr 
fast, and fitness level 
was calculated 
through a VO2max test 




increasing levels of 
fitness and decreased 
BMI. 
Physical activity an 
d cardiovascular 






activity during middle 
and late years alters 
the risk of CVD. 
2,363 female 
subjects (37-69 years 
old). 
Cross sectional study. 
Questionnaires 
reported the number 
of hours spent 
walking flights of 
stairs climbed, city 
blocks walked, and 
sports participated 
weekly.  Body weight 




Walking and/or a 
lower BMI were 
inversely related to 
CVD risk.  Overall, 
there is no 
association of 
physical activity and 
CVD risk in women. 
 
The literature reviewed examining the effects of physical activity on CRP levels were 
cross-sectional studies.  Most of the studies reviewed used both men and women over the age of 
40 years old as participants.  There was consistent evidence that physical activity was associated 
with decrease in CRP levels and lower risk of CVD.  There is an inverse relationship between 
activity level and CVD risk and CRP level; as activity levels increase, CRP levels decrease.
3, 10, 49
  
This relationship was demonstrated through three different methods of analyzing physical activity 
level.  The cross sectional studies that used questionnaires to determine participants’ physical 
14 
 
activity level concluded that increased physical activity resulted in lower CRP levels.
1,2,3,9,14
  
Other protocols used to determine physical activity level were 6-minute walk test, treadmill 
VO2max test, and cycle ergometer VO2max test.  Taffee
49
 concluded that increased activity level is 
associated with lower CPR levels after a 6-minute walk test to men and women over the age of 65 
was administered.  The Bruce treadmill protocol was utilized to measure the VO2max in middle 
aged men and women, and the only cross sectional study conducted on postmenopausal women 
utilized a cycle ergometry test to measure VO2max.
3, 29 
 Both of the VO2max protocols reported a 
higher VO2max measurement and was associated with lower CRP levels.  It is important to note 
that physical activity must be maintained though out life to maintain lower CRP levels and a 
lower risk of developing CVD.
10
   
Physical activity has been shown to decrease the risk of CVD in women, but intensity is 




reported 80% lower risk for a cardiovascular risk and decreased 
CPR level if moderate to vigorous activity was performed for 30 minutes most days of the week, 
while Sesso
47
 reported that light activity, such as walking, can reduce the CVD risk by 33% but 
the relationship was not significant enough to state that physical activity is associated to CVD.  
Interestingly, a meta-analysis by Oguma
37
 reported that walking 1 hour/week can decrease CVD 
risk according to the dose-response relationship.   
Table 4: Effects of C-Reactive Protein with Weight Loss through Physical Activity 
Article Problem/Question 
Studied 







To assess the effects 
of 3-month formal 




sensitivity CRP levels 
in patients with 
coronary heart 
disease. 
277 patients with 
CHD (235 completed 
cardiac rehab 
program while 42 
were the control 
group and did not 
receive rehab). 
Diet modifications to 
promote weight loss 
and exercise 
intervention were 
implemented 3 d/wk; 
blood samples were 
taken 2-6 weeks 
after hospital 









cardiac risk factors; 











Participants Procedures Findings 
Leisure time 
physical activity and 
reduced plasma 




To investigate the 
relationship between 
physical activity and 
the obesity related 
inflammatory marker 
C-reactive protein. 
405 healthy men and 
454 healthy women. 
Cross-sectional 
study from 1986 and 
1997; Blood samples 
were requested 
between 1993-1995; 
diet was assessed 
every 4 years; 
physical activity was 




activity is associated 




contrast to fat mass, 
inflammation 
markers explained 
little regarding the 





disease correlates of 
low cardio-




To describe the 
prevalence of low 
fitness in the US 
population aged 12-
49 years and to relate 
low fitness to CVD 
risk factors. 
 
Cohort study of 
3,110 12-19 yr olds 




collected via phone, 
physical 
examinations and lab 
measurements were 
performed in a 
mobile center, and 
blood samples were 
collected locally. 
Low cardio-
respiratory affects 1 
out of 5 persons 
aged 12-49 resulting 
in higher BMI; 
therefore, BMI is 
inversely related to 
fitness level. 
Association of 
physical activity and 
body mass index 






To examine the 
association of 
physical activity, BMI 





healthy US women.  
Cross sectional 
study; self reported 
height and weight 
and questionnaire for 




Lower levels of 
physical activity and 






Effect of weight loss 
and lifestyle changes 
on vascular 
inflammatory 
markers in obese 
women (Esposito, 
2003). 
To determine the 
effect of lifestyle 
changes to reduce 
body weight on 
markers of systemic 
vascular 
inflammatory and 
insulin resistance.  
120 premenopausal 
obese women (20-46 
years). 
24 m. intervention; 
Mediterranean 1300 
kcal diet and 
increased physical 
activity  
Reduction in weight 
loss was associated 
with reduction in 
vascular 
inflammatory 




levels with weight 







To determine whether 
improvements in 
insulin sensitivity 
with weight loss are 
mediated by changes 















fasting blood profile, 
and graded treadmill 
test; weekly 
meetings with a RD, 
3 d/wk exercised on 
treadmills or bikes. 
Body weight, 
percentage body fat, 
fat mass, fat free 




however VO2max did 
not change after 












Participants Procedures Findings 
Can exercise training 





To examined the 
effects of exercise 
training with weight 
loss on CRP levels 
and conventional 
CVD risks. 
199 healthy Japanese 
women (129 
postmenopausal).  
2 m intervention; 
subjects did aerobic 
exercise 2 d/wk (80 
min dance and 30-60 
min treadmill); 
blood samples (after 




and CV endurance 
were tested at 




decreased and CRP 
levels were lowered 
after exercise 
intervention; 
adipose tissue is 




Lifestyles changes, especially physical activity, can promote significant improvements of 
CVD risk factors, such as decreased CRP levels.  Cross sectional and 3-month intervention 
studies with men and women reported that independent of weight loss, with an increase in 
physical activity there was a decrease in CRP levels.
30, 40
  Along with decreased inflammatory 
markers, decreased weight, body fat percentage, adipose tissue, and BMI result from increased 
physical activity.
8,45
  Cross sectional with men and women and 6-month intervention with 
postmenopausal women concluded that there is an inverse relationship between BMI and physical 
activity level.  Intervention studies consisted of postmenopausal women exercising 3 days/week 
running or cycling for 30-60 minutes at 60% VO2max or between 60-80% peak heart rate.
38, 45
   
There was an inconsistency within the literature regarding the effect of decreased BMI has on 
CRP level.  According to Okita et al,
38
 CRP levels were affected by the decrease in adipose 
tissue; however, Milani et al
30
 reported the decrease in CRP levels were independent of weight 







Thirty-one women responded to the initial request for study volunteers.  Twenty-one 
postmenopausal women who were recruited from the James Madison University and 
Harrisonburg Rockingham County communities volunteered as participants for this study.  The 
subjects were reached through email flyers, e-mail, and by word of mouth.  Persons who showed 
interest in participating were screened to see if they met the minimum criteria for entrance into 
the study.  The criteria for inclusion included: Apparently healthy (no diagnoses of cardiovascular 
disease), female, post-menopausal (no regular menstrual cycle in the past 12 months), and 
previously sedentary (no regular exercise (<2 days per week) in the past 6 months).  All study 
protocols and procedures were approved by the Institutional Review Board. 
Overview of Procedures 
 
The protocol was designed to determine the independent effects of weight loss initiated through 
dietary changes and fitness (VO2max) without weight loss on CRP levels in post menopausal 
women.  Some of the measurements were used for other studies and are not related to the research 
question being investigated.  Pre- and post testing measurements were completed during separate 
four sessions.   
First Session 
 
During the first pre-test session all test procedures and protocols were explained to the 
participants who completed an Informed Consent Form (Appendix I), Health Status 
Questionnaire (Appendix II) and PAR-Q (Appendix III).  In addition, all participants were given 
a Dietary 24-hour Food Recall (Appendix IV) explained by a registered dietitian.  The ACSM’s 
Coronary Artery Disease Risk Factor Thresholds along with the ACSM Risk Stratification were 
used to assess the risk for cardiovascular disease.  Risk stratification was based upon age, family 
history, smoking habits, blood lipid levels, CRP levels (non-traditional risk factor), fasted blood 
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glucose values, resting blood pressure, body mass index, and physical activity habits.  Other 
questionnaires completed, but not used for the current study included: the International Physical 
Activity Questionnaire (IPAQ) designed to assess the volume of physical activity that the 
participant engaged in prior to enrolling in the study, the Pittsburgh Sleep Quality Index (PSQI) 
to assess the sleep quality of the participants, the Epworth Sleepiness Scale (ESS) evaluated the 
tendency to doze off during daytime activities, the U.S Department of Health and Human 
Services Health Behavior Questionnaire to assess lifestyle behaviors, and the Health Related 
Quality of Life questionnaire (HRQOL-4) assessed health related quality of life.     
Second Session 
 
The second session included a venous blood draw, measurement of resting blood pressure, and 
body composition assessment via dual-energy x-ray absorptiometry (DEXA Hologic, Bedford, 
Massachusetts).  After an overnight fast, blood obtained from the anticubital vein and was stored 
at -80
o
C until serum was analyzed for CRP.  Serum CRP levels were determined using an 
Enzyme Linked Immunoassay (ELISA) kit (BioCheck Inc, Foster City, California).  Blood lipid 
values (total cholesterol, HDL cholesterol, triglycerides) were measured and determined using 
dry slide technology (Johnson and Johnson Vitro DT 6011, Rochester, New York).  LDL 
cholesterol values were obtained using the Friedewald equation.  Blood lipid values were not 
included for analysis in the current study.  Height was measured to the nearest 0.25 cm and body 
weight was measured to the nearest 0.25 pounds to calculate BMI (kg/m
2
).  Also, waist 
circumference was measured at least twice to the nearest centimeter using a tension-controlled 
tape measure according to procedures as specified in the ACSM Guidelines for Exercise Testing 
and Prescription (eighth edition, 2009).  
Third Session 
 
The third session included a graded walking test on a treadmill (Quinton Club Track 612, Bothell, 
Washington) (Appendix V) to determine cardiovascular endurance (maximal oxygen 
consumption VO2max).  Oxygen consumption, heart rate, and rating of perceived exertion were 
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monitored throughout the test.  Metabolic measures were calculated using open circuit spirometry 
via a computerized metabolic cart (Sensormedics Vmax 229, Yorba Linda, California).  At the 
end of the first stage, workload was increased by increasing the elevation (grade) on the treadmill 
every three minutes.  The protocol continued in the same manner for three minute stages until the 
participant reached volitional fatigue, their age-predicted maximal heart rate, asks to stop, or 
experiences adverse signs or symptoms (ACSM, 2010). 
Fourth Session 
 
The fourth pre-test session consisted of muscular strength, muscular endurance, and flexibility 
measurement used for a larger project.  Muscular strength of the upper and lower body was 
measured by completing a 5 repetition maximum (RM) on the chest press and leg press machines 
(Cybex, Medway, Massachusetts).  Participants completed a number of submaximal repetitions as 
a warm up.  A weight that was within 50-70% of perceived capacity for 5 repetitions was 
selected, and the participant completed 5 repetitions at this weight.  If 5 repetitions were 
successfully completed, weight increased following a 3 to 5 minute rest period and 5 more 
repetitions were attempted.  This protocol continued until the participant could no longer 
complete 5 repetitions at a selected weight.  Muscular endurance was measured by following 
ACSM push-up and curl-up test procedures.  For the push-up test, participants assumed the 
modified “knee push-up” position, with legs together, lower leg in contact with the mat and toes 
pointed, back straight and hands shoulder width apart.  The participant performed as many 
modified “knee push-ups” as possible by straightening the elbows and then lowering the body 
until the chin touched the mat.  For the curl-up test, participants assumed a supine position on a 
mat with the knees at 90-degree angles.  Arms were at the side with palms facing down and 
fingers touching a piece of masking tape.  A second piece of tape was placed 10 centimeters in 
front of the first piece.  A metronome was set to 50 beats per minute, and the participant 
performed curl ups in time to the metronome, lifting the shoulder blades off the mat to touch the 
second piece of tape.  The number of curl-ups performed without pausing, or a maximum of 25, 
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was recorded as the score.  Muscular flexibility was assessed using the V-Sit and Reach test.  
Participants sat without shoes with the soles of the feet flat against a sit-and-reach box 
(flexometer) at the 26-centimeter mark.  Participants slowly reached forward as far as possible, 
keeping the legs straight and both hands overlapped, and holding this position for approximately 
2 seconds.  The most distant point reached with the fingertips was recorded. 
Interventions 
Weight Loss: Dietary Intervention (DI) 
 
Participants were randomly assigned to a hypocaloric dietary intervention (DI) for 9 weeks. 
Participants reported to the James Madison University Human Performance Laboratory once a 
week for a body weight measurement.  The study’s goal for DI participants was an 8-10% weight 
loss from baseline weight.  Assessment of dietary and beverage intake by 24-hour Food Recall 
and dietary guidance administered by a registered dietician occurred pre-intervention, week six of 
intervention, and post-intervention.   
Maximal oxygen consumption (VO2max): Exercise Intervention (EXI)  
 
Participants randomly assigned to an exercise intervention (EXI) reported to James Madison 
University Crawford Fitness Center 3 days per week for 45-55 minute sessions.  The study’s goal 
for the EXI participants was to increase cardiovascular endurance from baseline VO2max.  
Cardiovascular training was initially set for each participant to train at 60% of VO2max and 
gradually progress to training at 75-80% of max by week 9 of the intervention; participants had 
the option of walking, cycling, elliptical, or rowing.  Resistance training consisted of a circuit of 
upper and lower body exercises designed to improve muscular strength and endurance.  
Participants trained at an intensity of that allowed each individual to perform between 8-15 
repetitions (60-70% of 1RM) per set.  The regimen began with one set of each exercise and 
progressed to 2 sets of each exercise by week 9 of the intervention.  Resistance exercises were 
performed on Cybex equipment (Cybex, Medway, Massachusetts).  Upper body exercises 
included chest press, bicep curl, triceps extension, and latissimus pull down.  Lower body 
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exercises will include leg extension, leg curl, leg press, and calf raises. Two additional resistance 
exercises were added to increase muscular strength and endurance of the core.  Exercise sessions 
also gradually increased in time.  Sessions started at 30 minutes and progressed to 60 minutes per 
session (30 minutes performing cardiovascular exercise and 30 minutes of resistance exercise).    
Statistical Analysis 
 
Differences in CRP levels and dependent variables (weight, BMI, fat mass, body fat percent, 
waist circumference, and VO2max) within the DI and EXI were compared  by repeated measures 
analysis of variance.  Post-hoc paired t-tests were performed on variables that demonstrated 
significance between interventions to determine significance in change (pre-post).  Descriptive 
statistics were calculated for each treatment and measurement.  SPSS statistical software package 
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Background: Cardiovascular disease (CVD) risk factors that are intensified in postmenopausal 
women include body fat, blood pressure, dyslipidemia, and high sensitivity C-reactive protein 
(CRP) levels.  CRP has been reported as an independent indicator of risk for cardiovascular 
events.  CRP is affected by multiple factors such as age, race, body mass index (BMI), and 
physical activity level.  The purpose of this study was to examine whether weight loss or exercise 
without weight loss had an impact on CRP levels.  Methods and Results: Twenty apparently 
healthy postmenopausal women were randomly assigned to a diet intervention group (DI) or an 
exercise intervention group (EXI) for a period of 9 weeks.  DI participants reported once a week 
for a body weight measurement and EXI participants were asked to attend three 45-60 minute 
sessions per week (cardiovascular and resistance training exercises).  There were no significant 
differences effects of time or treatment on CRP levels (p=0.077).  However, there was a 
significant change (-4.45 kg) in body weight (p=0.000, p< 0.05) and (-1.1 kg) change in fat free 
mass (p=0.041, p<0.05) in the DI group.  Our study found that there was no significance in the 
change in CRP within the DI or EXI group.  Conclusions: Body weight, FFM, and waist 
circumference all decreased significantly in the DI group; however, decreases in these variables 
did not appear to precipitate significant changes in CRP.  It is possible that a greater degree of 
weight loss (over a longer duration) may be necessary to decrease CRP levels.  There was no 
significance between EXI and dependant variables, including CRP, also suggesting that greater 










Cardiovascular disease (CVD) is the major cause of death among the U.S. population.
8, 16, 
33
 With aging, the risk of CVD proportionally increases; however, women are affected by CVD 
10 years after men.
25,33
  Risk factors for CVD in women are smoking (leading cause), 
hypertension, dyslipidemia, diabetes mellitus, obesity, sedentary lifestyle, and menopause.
6, 25, 33, 
44, 46
  Increased abdominal adiposity, associated with obesity, is a risk factor for CVD in women; 
the prevalence of obesity has increased over the past decade and currently one out of three 
women is classified as obese.  Obesity is a parallel factor to sedentary lifestyle, and studies have 
shown that moderate physical activity reduces the risk of CVD by 50% in women.  Schenck
46
 
reported in 2009 that 30% of women are overweight and 27% are classified as obese, and the risk 
for CVD in obese women increases 3-fold compared to lean women.
20, 25, 33
  Menopause decreases 
the estrogen levels and increases testosterone levels in postmenopausal women negatively 
affecting cardiovascular functions and metabolism resulting in an increase risk for CVD event, 
such as dyslipidemia resulting from increased testosterone.
25
   
In addition to the blood lipids, abnormal lipoprotein, C-reactive protein (CRP) and 
interleukin-6 levels are known risk factors for CVD in women.
3, 13, 15, 39, 46
  Inflammation markers 
have been determined to have a significant role in the development of atherosclerosis and CVD, 
but the relationship between the inflammation process and CVD is complex.
4, 16, 22
  In response to 
tissue inflammation, CRP is stimulated by interleukin-6, interleukin-1, and tumor neurosis 
factor.
22
  This response occurs when activated immune cells in the plaque produce inflammatory 
cytokines, stimulating the production of substantial amounts of interleukin-6.  Interleukin-6, in 
response, stimulates the production of large amounts of acute-phase reactants (C-reactive protein, 
serum amyloid A, and fibrinogen) in the liver.  Plasma concentration of CRP can increase 100-
fold after acute inflammatory stimulus.
5, 11, 42
  According to Hansson,
16
 cytokines have important 
biologic effects at all steps; however, their amplification at each step of  the cascade makes the 
measurement of downstream mediators such as CRP particularly useful for clinical diagnosis.  
25 
 
CRP is an independent indicator of risk for stroke, peripheral vascular disease, and vascular death 
among healthy men and women without any known vascular diseases and is a stronger predictor 
for CV events compared to LDL-C levels.
 5, 11, 42, 43
  Currently practitioners consider CRP value of 
less than 2 mg/L as healthy, and individuals who have CRP levels of 5mg/L or greater may be at 
an increased risk for a cardiac event within six months.
22, 26
   
CRP is affected by multiple factors such as age, race, body mass index (BMI), and 
physical activity level.
1, 3, 4, 9, 13, 14, 17, 18, 22, 28, 49, 52, 53
  CRP levels have been shown to increase with 
age; therefore, BMI and physical activity level have to counteract the natural rise in CPR levels.
22, 
28
  CRP is highly correlated with BMI and several studies have reported a strong correlation 
between total fat mass and visceral fat and CRP.





 have  
reported that subjects with a BMI >30 kg/m
2
 had elevated CRP levels and CRP levels were 270% 
higher in individuals in the top quintile of BMI compared to those in the bottom quintile.  In 
addition to BMI, a direct relationship between elevated CRP levels and abdominal fat distribution 
via waist circumference measurement has been documented.
17, 18, 52
  A waist circumference 
greater than 88 centimeters indicates higher BMI values and higher risk for CVD due to increased 
visceral fat and increase in serum resistin.
18, 51
  When comparing race, more black women are 
considered obese and have higher CRP levels than white women.
23
  Finally, CRP levels have 
been shown to have an inverse relationship with physical activity level.
29
  Increased physical 
activity levels are related to decreased fat and lower BMI resulting in decreased CPR levels.
1, 3, 14, 
29, 49
     
It has been observed that the lowest CRP levels in individuals with the highest activity 
levels.
1,3,10,14
  Physical activity is associated with a lower risk of subsequent CVD events; 
however, physical activity in young adulthood was not a predictor of CVD risk several decades 
later.
10 
 Along with an inverse relationship between physical activity level and CRP, there is an 
inverse association between intensity and/or frequency of exercise with CRP levels.  CRP levels 
decrease with more vigorous exercise or more frequent exercise.
1, 3, 49
  Multiple studies have 
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shown that with weight loss and exercise, CRP levels decrease in proportion to weight loss.
30, 38, 
40, 45
  Increased physical activity promotes decreased weight, body fat percentage, adipose tissue, 
and BMI resulting in decreased CRP levels.
45
  Intervention studies consisting of aerobic activity 3 
days/week through group exercise classes, treadmill, or cycling for 30-60 minutes at 60% VO2max 
or between 60-80% peak heart rate resulted in a decrease in body weight, percentage body fat, fat 
mass, fat free mass, visceral adipose tissue, and decrease in CRP levels, however VO2max did not 




   
Research has shown that CRP decreases with weight loss through diet alone.  The 
majority of diet interventions reviewed consisted of a 1200 kcal/day diet for a period of 12 weeks 
with obese women as the study population.
10, 14, 49
  The diet intervention protocols consisted of 
1200 kcal/week.
35, 36, 50
  Previous studies have solely investigated changes of  CRP levels resulting 
from weight loss through dietary alterations or weight loss through exercise.  It is unknown if 
weight loss or exercise status alone have an effect on CRP levels in sedentary, postmenopausal 
women.  The purpose of this study was to compare the effects of an exercise intervention versus a 
dietary intervention on traditional (BMI, percent body fat, waist circumference, physical activity 
level) and non-traditional (CRP) risk factors for cardiovascular disease in sedentary, post 
menopausal women.   
 
PARTICIPANTS AND METHODS  
Participants 
 
Thirty-one women responded to the initial request for study volunteers.  Twenty-one 
postmenopausal women who were recruited from the James Madison University and 
Harrisonburg Rockingham County communities volunteered as participants for this study.  The 
subjects were reached through email flyers, e-mail, and by word of mouth.  Persons who showed 
interest in participating were screened to see if they met the minimum criteria for entrance into 
the study.  The criteria for inclusion included: Apparently healthy (no diagnoses of cardiovascular 
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disease), female, post-menopausal (no regular menstrual cycle in the past 12 months), and 
previously sedentary (no regular exercise (<2 days per week) in the past 6 months).  All study 
protocols and procedures were approved by the Institutional Review Board. 
Overview of Procedures 
 
The protocol was designed to determine the independent effects of weight loss initiated through 
dietary changes and fitness (VO2max) without weight loss on CRP levels in post menopausal 
women.  Some of the measurements were used for other studies and are not related to the research 
question being investigated.  Pre- and post testing measurements were completed during separate 
four sessions.   
First Session 
 
During the first pre-test session all test procedures and protocols were explained to the 
participants who completed an Informed Consent Form (Appendix I), Health Status 
Questionnaire (Appendix II) and PAR-Q (Appendix III).  In addition, all participants were given 
a Dietary 24-hour Food Recall (Appendix IV) explained by a registered dietitian.  The ACSM’s 
Coronary Artery Disease Risk Factor Thresholds along with the ACSM Risk Stratification were 
used to assess the risk for cardiovascular disease.  Risk stratification was based upon age, family 
history, smoking habits, blood lipid levels, CRP levels (non-traditional risk factor), fasted blood 
glucose values, resting blood pressure, body mass index, and physical activity habits.  Other 
questionnaires completed, but not used for the current study included: the International Physical 
Activity Questionnaire (IPAQ) designed to assess the volume of physical activity that the 
participant engaged in prior to enrolling in the study, the Pittsburgh Sleep Quality Index (PSQI) 
to assess the sleep quality of the participants, the Epworth Sleepiness Scale (ESS) evaluated the 
tendency to doze off during daytime activities, the U.S Department of Health and Human 
Services Health Behavior Questionnaire to assess lifestyle behaviors, and the Health Related 






The second session included a venous blood draw, measurement of resting blood pressure, and 
body composition assessment via dual-energy x-ray absorptiometry (DEXA Hologic, Bedford, 
Massachusetts).  After an overnight fast, blood obtained from the anticubital vein and was stored 
at -80
o
C until serum was analyzed for CRP.  Serum CRP levels were determined using an 
Enzyme Linked Immunoassay (ELISA) kit (BioCheck Inc, Foster City, California).  Blood lipid 
values (total cholesterol, HDL cholesterol, triglycerides) were measured and determined using 
dry slide technology (Johnson and Johnson Vitro DT 6011, Rochester, New York).  LDL 
cholesterol values were obtained using the Friedewald equation.  Blood lipid values were not 
included for analysis in the current study.  Height was measured to the nearest 0.25 cm and body 
weight was measured to the nearest 0.25 pounds to calculate BMI (kg/m
2
).  Also, waist 
circumference was measured at least twice to the nearest centimeter using a tension-controlled 
tape measure according to procedures as specified in the ACSM Guidelines for Exercise Testing 
and Prescription (eighth edition, 2009).  
Third Session 
 
The third session included a graded walking test on a treadmill (Quinton Club Track 612, Bothell, 
Washington) (Appendix V) to determine cardiovascular endurance (maximal oxygen 
consumption VO2max).  Oxygen consumption, heart rate, and rating of perceived exertion were 
monitored throughout the test.  Metabolic measures were calculated using open circuit spirometry 
via a computerized metabolic cart (Sensormedics Vmax 229, Yorba Linda, California).  At the 
end of the first stage, workload was increased by increasing the elevation (grade) on the treadmill 
every three minutes.  The protocol continued in the same manner for three minute stages until the 
participant reached volitional fatigue, their age-predicted maximal heart rate, asks to stop, or 








The fourth pre-test session consisted of muscular strength, muscular endurance, and flexibility 
measurement used for a larger project.  Muscular strength of the upper and lower body was 
measured by completing a 5 repetition maximum (RM) on the chest press and leg press machines 
(Cybex, Medway, Massachusetts).  Participants completed a number of submaximal repetitions as 
a warm up.  A weight that was within 50-70% of perceived capacity for 5 repetitions was 
selected, and the participant completed 5 repetitions at this weight.  If 5 repetitions were 
successfully completed, weight increased following a 3 to 5 minute rest period and 5 more 
repetitions were attempted.  This protocol continued until the participant could no longer 
complete 5 repetitions at a selected weight.  Muscular endurance was measured by following 
ACSM push-up and curl-up test procedures.  For the push-up test, participants assumed the 
modified “knee push-up” position, with legs together, lower leg in contact with the mat and toes 
pointed, back straight and hands shoulder width apart.  The participant performed as many 
modified “knee push-ups” as possible by straightening the elbows and then lowering the body 
until the chin touched the mat.  For the curl-up test, participants assumed a supine position on a 
mat with the knees at 90-degree angles.  Arms were at the side with palms facing down and 
fingers touching a piece of masking tape.  A second piece of tape was placed 10 centimeters in 
front of the first piece.  A metronome was set to 50 beats per minute, and the participant 
performed curl ups in time to the metronome, lifting the shoulder blades off the mat to touch the 
second piece of tape.  The number of curl-ups performed without pausing, or a maximum of 25, 
was recorded as the score.  Muscular flexibility was assessed using the V-Sit and Reach test.  
Participants sat without shoes with the soles of the feet flat against a sit-and-reach box 
(flexometer) at the 26-centimeter mark.  Participants slowly reached forward as far as possible, 
keeping the legs straight and both hands overlapped, and holding this position for approximately 





Weight Loss: Dietary Intervention (DI) 
 
Participants were randomly assigned to a hypocaloric dietary intervention (DI) for 9 weeks. 
Participants reported to the James Madison University Human Performance Laboratory once a 
week for a body weight measurement.  The study’s goal for DI participants was an 8-10% weight 
loss from baseline weight.  Assessment of dietary and beverage intake by 24-hour Food Recall 
and dietary guidance administered by a registered dietician occurred pre-intervention, week six of 
intervention, and post-intervention.   
Maximal oxygen consumption (VO2max): Exercise Intervention (EXI)  
 
Participants randomly assigned to an exercise intervention (EXI) reported to James Madison 
University Crawford Fitness Center 3 days per week for 45-55 minute sessions.  The study’s goal 
for the EXI participants was to increase cardiovascular endurance from baseline VO2max.  
Cardiovascular training was initially set for each participant to train at 60% of VO2max and 
gradually progress to training at 75-80% of max by week 9 of the intervention; participants had 
the option of walking, cycling, elliptical, or rowing.  Resistance training consisted of a circuit of 
upper and lower body exercises designed to improve muscular strength and endurance.  
Participants trained at an intensity of that allowed each individual to perform between 8-15 
repetitions (60-70% of 1RM) per set.  The regimen began with one set of each exercise and 
progressed to 2 sets of each exercise by week 9 of the intervention.  Resistance exercises were 
performed on Cybex equipment (Cybex, Medway, Massachusetts).  Upper body exercises 
included chest press, bicep curl, triceps extension, and latissimus pull down.  Lower body 
exercises will include leg extension, leg curl, leg press, and calf raises. Two additional resistance 
exercises were added to increase muscular strength and endurance of the core.  Exercise sessions 
also gradually increased in time.  Sessions started at 30 minutes and progressed to 60 minutes per 






Differences in CRP levels and dependent variables (weight, BMI, fat mass, body fat percent, 
waist circumference, and VO2max) within the DI and EXI were compared  by repeated measures 
analysis of variance.  Post-hoc paired t-tests were performed on variables that demonstrated 
significance between interventions to determine significance in change (pre-post).  Descriptive 
statistics were calculated for each treatment and measurement.  SPSS statistical software package 
(SPSS, Somers, New York) was used for all data analysis. 
 
RESULTS  
 Thirty-one women responded to the study’s advertisement and twenty-one women agreed 
to be participants in the study and completed pre-testing.  Twenty sedentary, postmenopausal 
women (48-67 years; DI group 56 ± 4.35 and EXI group 59.8 ± 5.88 years) completed the study.  
One woman completed pre-testing but discontinued the study prior to the intervention phase.  Ten 
women were randomly assigned to the diet intervention group and 10 women were randomly 
assigned to the exercise intervention group.  Table 5 illustrates the change in dependant variables 
pre and post intervention.  
Table 5: Differences in pre-measurements and post-measurements. 
Measurement DI Pre DI Post DI ∆ EXI Pre EXI Post EXI ∆ 
CRP (mg/L)   3.69 ± 2.01    2.83 ± 2.84   -0.86 ± 1.09    2.27  ± 1.97     3.07 ± 2.57  0.79 ± 1.09 
Weight (kg)*  83.4 ± 17.9  79.7 ± 17.6 -4.4 ± 2.3  66.9 ± 10.3   66.5 ± 10.8   -0.3 ± 1.0 
Fat Free Mass (kg)*   46.6 ± 6.4    45.5 ± 6.3 -1.0 ± 1.7 40.3 ± 4.2 40.5 ± 4.7    0.1 ± 0.5 
BF %   42.7 ± 5.1    41.0 ± 5.8 -1.7 ± 1.5 38.1 ± 6.8 37.4 ± 7.0   -0.6 ± 0.8 
BMI (kg/m2)*   31.7 ± 6.6    30.1 ± 6.6 -1.6 ± 0.8 26.1 ± 4.4 26.2 ± 4.7    0.3 ± 0.8 
WC (cm)*  89.3 ± 11.4  86.1 ± 11.9 -3.2 ± 2.5 81.1 ± 7.6 81.1 ± 8.6   -0.0 ± 1.9 
VO2max (L/min)   2.02 ± 0.30   1.99 ± 0.20 -0.02 ± 0.18   1.81 ± 0.23   1.86 ± 0.26 0.04 ± 0.12 
VO2max (mL/kg/min) 24.93 ± 5.87 26.19 ± 6.65  1.26 ± 2.17 27.77 ± 4.89 28.59 ± 5.30 0.82 ± 1.94 
All values reported as mean ± standard deviation. 
*p<0.05 
 
There was no significant effect of time (p=0.971) or treatment (p=0.717) on CRP level.  
There were statistical differences in baseline weight (p=0.019, p<0.05) and baseline FFM 
(p=0.018, p<0.05) between the DI and EXI groups.   
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Figure 2 provides pre and post measurements of weight and FFM variables.  There was 
significant time x treatment effect for both weight and FFM (p<0.05).   The DI group experienced 
a significant decrease in weight (-4.4 ± 2.3 kg).  Although there was a time x treatment effect, 
FFM did not change from pre- to post-testing for either the DI o EXI group (p=0.076 and 
p=0.369, respectively) after performing paired t-tests.  Figures 3 and 4 provide pre- and post-
measurements of BMI and waist circumference variables.  There was a time x treatment effect for 
BMI (p=0.000) and waist circumference (p=0.005). The change in BMI was -1.6 ± 0.8 kg/m
2
 
(p=0.000) and the change in waist circumference was -3.2 ± 2.5 cm (p=0.003) within the DI 
group.  There was no difference in BMI or waist circumference in the EXI group.  No difference 
in body fat percentage (p=0.072) was found within groups because the objective of the EXI group 
was to maintain weight; these aforementioned findings were expected. 
  There was no difference (p<0.05) in VO2max (mL/kg/min) in either of the intervention 
groups.  The objective of the DI group was to maintain fitness level; therefore in the lack of 
change in VO2max was expected.  The participants in the EXI group were asked to report 3 days 
per week (27 sessions total) to complete a cardiovascular and resistance training circuit; 
participants attended 24.6 ± 2.59 sessions during the intervention phase.  Unfortunately, the aim 




Figure 1: Changes in CRP pre and post intervention. 
       DI   = Dietary Intervention 





Figure 2: Pre and post measurements of body weight and fat free mass. 
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Figure 3: Pre and post measurements of body mass index. 
                * p < 0.05 
 
 
Figure 4: Pre and post measurements of waist circumference. 
       * p < 0.05 
 
DISCUSSION 
The purpose of this study was to compare the effects of an exercise intervention versus a 
dietary intervention on traditional (BMI, waist circumference) and a non-traditional (CRP) risk 
factor for cardiovascular disease in sedentary, postmenopausal women.  Previous research has 
















































25, 41, 44, 53
  In addition, obesity has been determined to be a risk factor for increased risk for CVD 
and potentially precipitating elevated CRP.
13, 20, 54
  Previous studies have reported that body 
weights between 92-130 kg and/or a BMI between 25-46 kg/m
2
 were associated with CRP levels 
above 3 mg/L.
12, 18, 19, 23, 32, 39, 50, 51, 54
  Individuals with a CRP level less than 2 mg/L are classified 
as healthy, above 3 mg/L are considered at high risk for cardiovascular events, and above 5 mg/L 
may be at an increased risk for a cardiac event within six months.
22, 26
  Our study found that there 
was no change in CRP with either intervention. 
 Even though CRP levels did not significantly change, there was a significant difference in 
body weight and fat free mass in the DI group.  It is possible that the participants’ baseline CRP 
levels were classified as “at moderate risk” and that the weight loss was not great enough to elicit 
a significant decrease in CRP levels.  It has been reported that with a greater reduction in weight 
loss there is a greater reduction in CRP level; Heilbronn
17, 18
 reported a 26% decrease in CRP 
level with a 7.9 kg decrease after 12 weeks and Tchernof 
50
 stated a 32% decrease in CRP with a 
weight loss of 15.6 kg after a 14 week intervention.  Thus a greater degree of weight loss (over a 
longer duration) may be necessary to decrease CRP levels.  The BMI of participants in the DI 
group were classified as obese class I, but CRP levels were not classified as “at risk”.  Therefore, 
an elevated BMI may be needed to observe a greater change in CRP levels.  Nicklas
34
 reported 
that there was a significant difference in CRP among the diet-induced weight loss group; 
however, the baseline mean BMI was 34 kg/m
2
 and mean CRP was 6.0 g/mL.  The current 
study’s baseline measurements of body weight, BMI, and CRP were lower than participants in the 
Nicklas
34
 study.   
The relationship between physical activity and CRP is not well defined.  Previous studies 
investigating physical activity level and CRP have been primarily cross-sectional studies and the 
consensus appears to be that higher physical activity level are associated with a lower BMIs 
which results in lower CRP level.
1, 2, 3,29, 47
  To our knowledge there are no previous studies that 
have reported that an increase in physical activity levels of individuals with elevated BMIs results 
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in lower CRP levels, without concomitant changes in body weight or body fat.  The investigators 
have not been able to distinguish the independent effects of body weight (body fat) or fitness on 
CRP.  In the current study, physical activity only had minimal effects on the dependant 
measurement of body fat percentage and fat free mass due to maintenance of body weight.  
Decreases in body fat percentage and increases in fat free mass from weight loss through exercise 
are generally associated with decreases in CRP levels.
8,39
  Past research regarding weight loss 
through exercise has concluded that there is an inverse relationship with between physical activity 
and BMI.
8, 31, 45
  Currently, there is controversy in the literature concerning the effect that weight 
loss [decrease in adipose tissue] due to physical activity has on CRP level.  Okita and colleagues
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showed that CRP levels are affected by the decrease in adipose tissue from weight loss due to 
physical activity, while other studies reported that independent of weight loss, with an increase in 
physical activity there was a decrease in CRP levels.
30, 40
 The findings of the current study are 
unique in that the exercise intervention was designed to increase fitness without weight loss in an 
attempt to determine the independent effect of fitness on CRP levels.  The exercise program  was 
not effective in increasing the participants VO2max.  There were varied adaptations to the exercise 
intervention.  According to ACSM, a VO2max value of 28.7 mL/kg/min is classified as “fair” for 
women between 50-60 years old.  Out of the 10 women in the EXI group, 5 were classified below 
fair (poor) and 5 were classified as fair, good, or excellent pre-intervention.  Post-intervention, 6 
women increased their VO2max from the EXI group.  VO2max did not change in the DI group 
regardless of the significant change in body weight; however, the objective of the DI group was 
to lose weight and not increase fitness.  The majority of earlier investigations that have examined 
the relationship between physical activity and CRP have reported that low cardiorespiratory 
fitness is associated with elevated CRP levels.
 1, 2, 3,29, 47  
The current study’s findings can be 
compared to the findings in the Nicklas
34
 study in which participants were assigned to a 3 month 
exercise intervention that consisted of cardiovascular endurance (50-75% of heart rate reserve) 
and resistance training regimen for 3 days per week for 45 minutes.  The authors of previously 
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published studies have reported that there was no significant differences in CRP levels after an 
exercise intervention.
34
  In attempting to explain the lack on change in the CRP level in the EXI 
group, it may be a function of the low baseline values we measured in the study population prior 
to the intervention.  The CRP levels measured in the current study population were not classified 
as “at risk”.  Also, it may be possible that the intensity or duration of the exercise protocol was 
not enough to elicit change in VO2max and CRP, or the modified treadmill protocol did not 
effectively measure VO2max in this population of sedentary, postmenopausal women considering 
their chief complaint of being uncomfortable during the test.  Many participants stated they had a 
dry mouth from the mouthpiece; this uncomfortable (or unfamiliar) sensation may have made the 
participants stop the treadmill test prior to reaching a maximal effort.  From this inconsistent 
information, it can be stated a physical activity intervention without weight loss has an 
inconclusive result on CRP levels without an adequate overload to elicit a significant increase in 
VO2max. 
 Additional variables that were measured included BMI, body fat percentage, fat free 
mass, and waist circumference.  Previous studies concluded that a lower BMI is correlated with 
lower CRP levels.
18, 19, 32, 34, 50
  Studies that examined weight loss through physical activity have 
concluded that a 2-5 kg/m
2 
 decrease in BMI, a 2-3% decrease in body fat percentage, a 1-3 kg 
decrease in fat free mass, and 3-4% decrease in waist circumference were associated with a 
decrease in CRP level.
19, 45, 50, 52, 55
  With the significant changes in BMI (decrease 1.7 ± 0.8 
kg/m
2
)  and  waist circumference (decrease 3.2 ± 2.5 cm) in the DI, it was not a great enough 
change to  elicit a significant difference in CRP level.  Since the participants had an “at risk” BMI 
but not an “at risk” waist circumference or CRP level, it is possible that along with a BMI over 30 
kg/m
2
, waist circumference should be greater than 88 cm and CRP levels need to be above 3 






The findings presented above should be interpreted with caution in view of the limitations of the 
current study.  A greater number of participants may have resulted in the observance of larger 
differences in dependant measures between the two intervention groups.  Another limitation was 
the differences in the baseline measurements between the DI and EXI groups.  Although all 
participants were categorized as sedentary their BMI values ranged from healthy to obese.  Also, 
participants were volunteers that did not smoke and may have had a physical activity history prior 
to the past 12 months; the pre-intervention profiles may not have permitted for a statistical 
difference in CRP.   Perhaps more importantly, the sequence of baseline and post-testing sessions 
could have influenced CRP levels; some participants performed the VO2max or muscular fitness 
tests less than 24 hours prior to the fasted blood draw.  By performing exercise within 48 hours of 
the blood draw this may have a negatively influenced the CRP levels.  Finally, the compliance of 
the DI participants with the initial weight loss goal of 8-10% from baseline weight was a 
limitation; of the ten participant in the DI group, two women succeeded in achieving this goal, 
while four other women achieved a weight loss between 5-6%.   
Conclusion 
Our study found that there was no significance in the change in CRP within the DI or EXI group.  
The objective of decreasing weight was achieved because there was a significant difference in 
body weight, fat free mass, BMI, and waist circumference within the DI group.  These differences 
were not great enough to have a significant difference in CRP level though.  The objective of 
increasing VO2max was not achieved within the EXI group.  More research is needed to determine 
if an increase in fitness level without weight loss has an impact on CRP levels. 
Recommendations for Future 
The first recommendation for future studies would be to recruit a greater number of participants 
to form larger intervention groups and/or have a control group.  The second recommendation 
would be to have inclusion criteria in which participants are within overweight/obese category for 
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BMI and are at poor to very poor levels of cardiovascular endurance (VO2max).  Finally, a physical 
activity intervention study with a control group will enable an investigation of CRP levels with 





C-reactive protein is an inflammatory marker that is an independent indicator of risk for 
stroke, cardiovascular disease, and vascular death among postmenopausal women without any 
known vascular diseases and may be a stronger predictor for CV events compared to LDL-C 
levels.
5, 11, 42, 43  
Risk factors for CRP in women are age, smoking (leading cause), hypertension, 
dyslipidemia, obesity, sedentary lifestyle, and menopause.
6, 25, 33, 44, 46
  CRP levels have been 
shown to increase with age; therefore, controlling BMI and physical activity level may help to 
minimize the age dependent rise in CPR levels.
22, 28
  CRP is highly correlated with BMI; and 
several studies have reported a strong correlation between total fat mass and visceral fat and 
CRP.
17, 18, 23, 52  
Increased abdominal adiposity, associated with obesity, is a risk factor for CVD in 
women; the prevalence of obesity has increased over the past decade and currently one out of 
three women is classified as obese.  Obesity is a parallel factor to sedentary lifestyle, and studies 
have shown that moderate physical activity reduces the risk of CVD by 50% in women.  
Schenck
46
 reported in 2009 that 30% of women are overweight and 27% are classified as obese, 
and the risk for CVD in obese women increases 3-fold compared to lean women.
20, 25, 33
  
Menopause decreases the estrogen levels and increases testosterone levels in postmenopausal 
women negatively affecting cardiovascular functions and metabolism resulting in an increase risk 
for CVD event, such as dyslipidemia resulting from increased testosterone.  Currently 
practitioners consider CRP value of less than 2 mg/L as healthy, and individuals who have CRP 
levels of 5mg/L or greater may be at an increased risk for a cardiac event within six months.
22, 26
   
Studies have been conducted on the obese, postmenopausal population and older men and 
women to determine if weight loss through diet, physical activity, and/or physical activity with 
weight loss affects CRP levels.  Lifestyles changes, especially physical activity and diet, can 
promote significant improvements of CVD risk factors, such as decreased CRP levels.  Weight 
loss through low calorie diet has been shown to reduce CRP levels in obese, postmenopausal 
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women since the in CRP levels is primarily associated with loss in fat mass during weight loss.
50
  
There is fairly consistent evidence that physical activity is associated with decrease in CRP levels 
and lower risk of CVD.  There is an inverse relationship between activity level and CVD risk and 
CRP level; as activity levels increase, CRP levels decrease.
3, 10, 49
  Also, CRP levels decrease with 
more vigorous exercise or more frequent exercise.
1, 3, 49
   Along with decreased inflammatory 
markers, decreased weight, body fat percentage, adipose tissue, and BMI result from increased 
physical activity.
8, 45
  Previous studies have solely investigated changes of  CRP levels resulting 
from weight loss through dietary alterations or weight loss through exercise.  It is unknown if 
weight loss or exercise status alone have an effect on CRP levels in sedentary, postmenopausal 
women.  The purpose of this study was to compare the effects of an exercise intervention versus a 
dietary intervention on traditional (BMI, percent body fat, waist circumference, physical activity 
level) and non-traditional (CRP) risk factors for cardiovascular disease in sedentary, post 
menopausal women.   
Thirty-one women responded to the initial request for study volunteers. Twenty-one 
postmenopausal women who were recruited from the James Madison University and 
Harrisonburg Rockingham County communities volunteered as participants for this study.  
Persons who showed interest in participating were screened to see if they met the minimum 
criteria for entrance into the study. The criteria for inclusion included: Apparently healthy (no 
diagnoses of cardiovascular disease), female, post-menopausal (no regular menstrual cycle in the 
past 12 months), and previously sedentary (no regular exercise (<2 days per week) in the past 6 
months). Participation in the study was entirely voluntary and withdrawal at anytime was allowed 
without any consequences. All study protocols and procedures were approved by the Institutional 
Review Board.  Pre and post testing measurements were completed during separate four sessions.  
During the first pre-test session all test procedures and protocols were explained to the 
participants who completed an Informed Consent Form, Health Status Questionnaire, and PARQ.  
In addition, all participants were given a Dietary 24-hour Food Recall supervised by a registered 
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dietitian.  After an overnight fast, venous blood draw, measurement of resting blood pressure, and 
body composition assessment via dual-energy x-ray absorptiometry.  Blood obtained from the 
anticubital vein was analyzed for CRP.  The third session included a graded walking test on a 
treadmill to determine cardiovascular endurance (maximal oxygen consumption VO2max).  
Oxygen consumption, heart rate and rating, of perceived exertion (RPE) were monitored 
throughout the test.  The fourth pre-test session consisted of muscular strength, muscular 
endurance, and flexibility measurement used for a larger project.   
The protocol in this study was designed to determine the independent effects of weight 
loss initiated through dietary changes and fitness (VO2max) without weight loss on CRP levels in 
postmenopausal women.  Participants were randomly assigned to a diet intervention (DI) or 
exercise intervention (EXI) group.  The objective of the DI was to produce an 8-10% weight loss 
during the 9 week intervention through a 1,200 kcal/day diet.  Participants reported once a week 
for a body weight measurement, and assessment of dietary and beverage intake by 24-hour Food 
Recall and dietary guidance occurred pre-intervention, week six of intervention, and post-
intervention.  The objective of the EXI group was to increase cardiovascular fitness.  Participants 
in the EXI group were asked to report 3 days per week for 45-55 minute sessions.  Cardiovascular 
training was initially set for each participant to train at 60% of VO2max and gradually progress to 
training at 75-80% of max by week 9 of the intervention.  Resistance training consisted of a 
circuit of upper and lower body exercises designed to improve muscular strength and endurance.  
Participants trained at an intensity of that allowed each individual to perform between 8-15 
repetitions (60-70% of 1RM) per set.  Sessions started at 30 minutes and progressed to 60 
minutes per session. 
There was no significant effect of time (p=0.971) or treatment (p=0.717) on CRP level.  
There were statistical differences in baseline weight (p=0.019, p<0.05) and baseline FFM 
(p=0.018, p<0.05) between the DI and EXI groups.   
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There was significant difference with weight within (p=0.000) and FFM (p=0.04) and 
between (p=0.031 and p=0.03) groups following the intervention.  The DI group experienced 
significant difference in change (∆) in weight -4.4 ± 2.3 kg (p=0.000).  Although significance was 
found in FFM within groups, no significance was found in the DI o EXI group (p=0.076 and 
p=0.369, respectively) after performing a paired t-test.  Figure 2 provides pre and post 
measurements of weight and FFM variables.  There was significant difference in BMI (p=0.000) 
and waist circumference (p=0.005), but there was not a difference between interventions 
(p=0.090) and (p=0.161), respectively.  The change in BMI was -1.6 ± 0.8 kg/m
2
 (p=0.000) and 
the change in waist circumference was -3.2 ± 2.5 cm (p=0.003) within the DI group.  There was 
no difference in BMI or waist circumference in the EXI group.  Figures 3 and 4 provide pre and 
post measurements of BMI and waist circumference variables.  No difference in body fat 
percentage (p=0.072) was found within groups.  The objective of the EXI group was to maintain 
weight; therefore, having no significance in body weight, BMI, or waist circumference is a 
positive result.    
 Regarding fitness level, there was no difference in VO2max (mL/kg/min) within (p=0.639) 
or between (p=0.312) intervention groups.  The objective of the DI group was to maintain fitness 
level; therefore no significant difference in VO2max is a positive result.  Unfortunately, the aim of 
the EXI group was to increase fitness and this goal was not achieved.       
Even though significance was not found in CRP levels, there was a significant difference 
in body weight and fat free mass in the DI group.  It is possible that the participants’ baseline 
CRP levels were classified as “at moderate risk” and that the weight loss was not great enough to 
elicit a significant decrease in CRP levels.  It has been reported that with a greater reduction in 
weight loss there is a greater reduction in CRP level; Heilbronn
17, 18
 reported a 26% decrease in 
CRP level with a 7.9 kg decrease after 12 weeks and Tchernof 
50
 stated a 32% decrease in CRP 
with a weight loss of 15.6 kg after a 14 week intervention.  Thus a greater degree of weight loss 
(over a longer duration) may be necessary to decrease CRP levels.  The BMI of participants in the 
44 
 
DI group were classified as obese class I, but CRP levels were not classified as “at risk”.  
Therefore, an elevated BMI may be needed to observe a greater change in CRP levels.  The 
current study’s baseline measurements of body weight, BMI, and CRP were lower than 
participants in the Nicklas
34
 study.  Nicklas
34
 reported that there was a significant difference in 
CRP among the diet-induced weight loss group; however, the baseline mean BMI was 34 kg/m
2
 
and mean CRP was 6.0 g/mL. 
To our knowledge there are no previous studies that have reported that an increase in 
physical activity levels of individuals with elevated BMIs results in lower CRP levels, without 
concomitant changed in body weight or body fat.  In the current study, physical activity did not 
elicit a significant change in body fat percentage and fat free mass due to maintenance of body 
weight.  Decreases in body fat percentage and increases in fat free mass from weight loss through 
exercise are generally associated with decreases in CRP levels.
8,39
  The majority of  previously 
published studies that have investigated the relationship between physical activity and CRP have 
reported that low cardiorespiratory fitness is associated with elevated CRP levels.
 1, 2, 3,29, 47  
The 
current study’s findings can be compared to the findings in the Nicklas
34
 study in which 
participants were assigned to a 3 month exercise intervention that consisted of cardiovascular 
endurance (50-75% of heart rate reserve) and resistance training regimen for 3 days per week for 
45 minutes.   
Our study found that there was no significance in the change in CRP within the DI or 
EXI group.  The objective of decreasing weight was achieved because there was a significant 
difference in body weight, fat free mass, BMI, and waist circumference within the DI group.  
However, these changes were not great enough to precipitate a significant difference in CRP, 
which may be related to the initial low levels demonstrated in the study population.  The 
objective of increasing VO2max was not achieved within the EXI group and thus it is not surprising 
that CRP did not change in addition to the fact that again the levels in the group were not 
considered “at risk” or elevated.  More research, through intervention studies, is needed to 
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James Madison University 
Departments of Kinesiology and Health Sciences 
Consent for Investigative Procedure 
(Informed Consent) 
 
You are being asked to participate in a research study Women Inflammation Atherosclerosis and 
Thrombosis (WAIAT) conducted by Drs. Judith A. Flohr, Jeremy Akers, Nicholas Luden, R. Theresa 
Prodoehl and Christopher J. Womack from the Departments of Kinesiology and Health Sciences at James 
Madison University. The purpose of this study is to determine the effects of diet induced weight loss and 
exercise on traditional (blood pressure, blood lipids, BMI, blood glucose) and nontraditional risk factors (markers 
of chronic inflammation hsCRP, IL-6, fibrinolysis profile (blood clotting potential), endothelial (lining/wall of 
blood vessel function) function, and sleep quality) for cardiovascular disease (CVD) by using a randomized 
controlled intervention trial in post menopausal women. 
 
Research Procedures: 
The study will consist of various supervised lab tests and questionnaires to measure the physical fitness, 
health status, lifestyle behaviors, body composition, blood lipids and blood glucose, and risk for 
cardiovascular disease in women.  
 
Note: In the event you discover that any of the following information is not clear, please ask one 
of the investigators to explain immediately. 
 
In this study I understand I will be randomly assigned to one of the following intervention groups 
Exercise Intervention (Training Protocol) Participants in this group will follow the program described 
below 
Frequency-  Three (3-5) days per week, 45-55 minutes/session (Participants will be asked to 
complete 3 to5 supervised sessions per week. 
Intensity- Cardiovascular training will initially be set so that each participant is training at 60% of 
her VO2max (maximal oxygen consumption) and gradually progress to training at 75-80% of max 
by week 10 of the  intervention. Resistance training- participants will perform a circuit of upper 
and lower body exercises designed to improve muscular strength and endurance. Participants will 
train at an intensity of that allows each individual to perform between 8-15 repetitions (60-70% of 
1 Repetition Maximum (1RM) per set. The program will start with one set of each exercise and 
progress to 2 sets of each exercise by week 10 of the intervention.  
Time- Exercise sessions will start at 30 minutes and progress so that by week 10 of the 
intervention each participant is spending approximately 20 minutes performing cardiovascular 
exercise and 20 minutes of resistance exercise during each exercise session for a total of 40 
minutes per session. 
Type-Cardiovascular- Participants will have the option of walking, cycling, elliptical or rowing as 
modes of cardiovascular training.  Resistance exercises will be performed on selectorized 
equipment.  Upper body exercises will include chest press, bicep curl, triceps extension and lat 
pull down. Lower body exercises will include leg extension, leg curl, leg press and calf raises. 
Two additional resistance exercises will be added to increase muscular strength and endurance of 
the core (i.e. abdomen and back). 
Maintenance of weight- Participants in the EXI group will be asked to maintain baseline body 
weight. Dietary 24-hr Food Recalls will be given to assess dietary and beverage intake. 
 
Dietary Intervention Participants in this group will be asked to come to the Human Performance Laboratory 
(Godwin Hall 209) once a week for a body weight measure, assessment of dietary and beverage 






In this study I understand the following measurements and tests will be taken: 
Blood Pressure.  Blood pressure measurements will be taken using a sphygmomanometer and stethoscope.  
A blood pressure cuff will be placed over the brachial artery of the right arm, slightly above the elbow. 
 
Blood Draws: A blood sample (10 milliliters, 2 teaspoons) will be obtained from each participant via 
venapuncture of the antecubital vein during the test sessions #2 and #5. The following procedures will be 
followed to minimize the transfer of blood-borne pathogens: investigators will wear latex gloves at all 
times during blood sampling and testing. For each venous blood draw, the following measurements will be 
taken: Blood lipids (total cholesterol (TCHOL), low density lipoprotein cholesterol (LDL-C) high density 
lipoprotein cholesterol (HDL-C), triglycerides (TRIG), Hematocrit (packed cell volume), Hemoglobin 
(Hb), markers of inflammation (High sensitivity C-Reactive Protein (hsCRP),Interleukin 6 (IL-6)), Blood 
clotting factors (Tissue plasminogen activator (tPA)  and plasminogen activator inhibitor (PAI), 
vonWillenbrand factor) and blood glucose.  
 
Health Status Health status will be determined via questionnaires and ACSM’s Risk Stratification for 
Cardiovascular Disease Risk (ACSM, 2010). Assessment of a woman’s risk for cardiovascular disease will 
be made using the ACSM’s Coronary Artery Disease Risk Factor Thresholds along with the ACSM Risk 
Stratification. Risk stratification is based upon age, family history, smoking habits, blood lipid levels, and 
fasted blood glucose values, resting blood pressure, body mass index and physical activity habits.   
 
Health Related Quality of Life (HRQOL-4) –Health related quality of life status will be assessed using a 
4 item questionnaire developed by the Centers for Disease Prevention and Control. The CDC’s HRQOL-4, 
also referred to as the Healthy Days Core Module, will assess when the participant has felt that her physical 
or mental health was not good in the previous 30 days 
 
Physical Fitness – A series of physical fitness tests will be administered.  The components of fitness to be 
measured include cardiovascular endurance, muscular strength and endurance, and muscular flexibility.    
 a. Cardiovascular endurance. Cardiovascular endurance will be assessed through a walking test 
performed on a treadmill.  Oxygen consumption, blood pressure, heart rate and rating of perceived exertion 
(RPE) will be monitored throughout the test.  The workload will be increased gradually by raising the 
elevation (grade) on the treadmill every three minutes.  The test will continue in the same manner every 
three minutes until the participant reaches volitional (voluntary) fatigue, their age-predicted maximal heart 
rate or asks to stop. 
 b. Muscular strength.  Upper body strength will be assessed using the chest press machine.  You 
will be asked to perform five repetitions on the chest press; the weight will be increased until you can no 
longer complete five repetitions or at the point you wish to stop the test.   Lower body strength will be 
assessed using the leg press machine and will follow the same steps and the bench press test.  A minimal 
level of discomfort is associated with the completion of the muscular strength tests due to muscle soreness, 
which may be felt 24-72 hours after the completion of the test.  
 c. Muscular endurance. Muscular endurance will be measured by following ACSM (2010) push-
up and curl-up test procedures.  For the push-up test, participants assume the modified “knee push-up” 
position, with legs together, lower leg in contact with the mat and toes pointed, back straight and hands 
shoulder width apart.  The participant performs as many modified “knee push-ups” as possible by 
straightening the elbows and then lowering the body until the chin touches the mat.  The maximal number 
of push-ups performed correctly and without rest recorded as the score (ACSM, 2010).  For the curl-up test, 
participants will assume a supine (face up) position on a mat with the knees at 90-degree angles.  Arms will 
be at the side with palms facing down and fingers touching a piece of masking tape.  A second piece of tape 
is placed 10 centimeters in front of the first piece.  A metronome is set to 50 beats per minute, and the 
participant does curl ups in time to the metronome, lifting the shoulder blades off the mat to touch the 
second piece of tape.  The number of curl-ups performed without pausing, or a maximum or 25, is recorded 
as the score (ACSM 2010).   
 d. Muscular flexibility. Muscular flexibility will be assessed using the V-Sit and Reach test.  
Participants will sit without shoes with the soles of the feet flat against a sit-and-reach box (flexometer) at 
the 26-centimeter mark.  Participants will slowly reach forward as far as possible, keeping the legs straight 





 a. Exercise Behavior – The volume of physical activity that the participant engaged in prior to 
enrolling in the study will be estimated using the International Physical Activity Questionnaire (IPAQ). The 
questionnaire consists of 5 activity domains, asked independently, in which the participant reports about the 
time spend being physically active in the last 7 days. 
 b. Dietary Behavior –Dietary 24-hr Food Recalls will be taken from study participants to assess 
dietary intake including beverage consumption. Participants in both groups will be given proper dietary 
interventions by a Registered Dietitian. Two-dimensional food diagrams will be provided to assist 
participants in portion size determination. All food and beverage records will be reviewed for accuracy and 
completeness and analyzed using the NutritionistPro nutrition analysis software. 
 c. Sleep Quality –Participants will complete the Pittsburgh Sleep Quality Index (PSQI) which has 
19 self-rated questions about sleep over the past month   
 d. Daytime Sleepiness-Participants will complete the Epworth Sleepiness Scale (ESS) which has 8 
self-rated questions about tendency to doze during daytime. 
 e. Other Lifestyle Behaviors – Additional lifestyle behaviors will be assessed using the U.S 
Department of Health and Human Services Health Behavior Questionnaire.  The other behaviors being 
assessed include smoking status, use of alcohol and drugs, and stress. 
 
Body Weight and Composition. Height and body weight of all participants will be measured to calculate 
body mass index BMI (kgs/m2).  Dual-energy x-ray absorptiometry (DEXA) will be used to estimate body 
composition data through the whole body scan.   Assessment will take place using the Hologic  DELPHI-
W. The participant will be asked to lie on their back, positioned on the machine according to protocol. They 
will be asked to lie completely still, while breathing normally, and closing their eyes while the scan 
absorptiometry is in progress. The whole body scan lasts approximately 6 minutes. The DEXA analysis 
provides the most accurate method available to assess body composition. According to the manufacture’s 
specifications (i.e., Hologic Inc.), whole body DXA analysis exposes participants to 1.5 mrem of radiation.  
The exposure to radiation during a single chest x-ray (i.e., 5 mrem) is more than 3 times greater than 
radiation from DEXA.  Also, background radiation from DEXA is about equal to the amount of radiation 
one experiences during a flight from New York to London. Please note that the effects of the DEXA scan 
are cumulative depending on your prior exposure to radiation. If you have questions regarding your risk 
from the scan please consult with the investigators. 
 
Time Required: 
Total time to complete the test sessions is estimated to be: Test session #1 (Orientation session, 1 hour), 
Test session #2 and #4 (1 hour each), and test sessions #3 and 5 (1 hour each).  You will be allowed to rest 
as long as necessary between exercise testing stations. Participants in the Exercise Group will be asked to 
attend 3-4 exercise sessions (45-55 minutes in duration) for 10 weeks. Participants in the Dietary 
Intervention will be asked to come to the Human Performance Lab in Godwin once a week (30 minutes) for 




There is minimal risk associated with exercise testing in individuals who are “low risk” according to 
guidelines established by the American College of Sports Medicine.  There is a minimal level of discomfort 
that may be experienced during the exercise testing, which includes muscle soreness and fatigue.  Muscle 
soreness may be felt 24-48 hours following the testing.   
 
The risks of venipuncture blood sampling include possible mild bruising and the risk of transfer of blood-
borne pathogens.  This risk is considered to be minimal, and all safety precautions for handing blood 
samples will be followed according to Occupational Health and Safety Administration (OSHA) protocols. 
 
Benefits: 
You will receive the results from your individual fitness testing, including a rating of how you compare to 
females within your age category.  You will also receive information regarding your current risk factors for 





All data and results will be kept confidential. Participants will be assigned an identification code. At no 
time will a participant’s name be identified with individual data. All data will be secured in a locked 
cabinet in a locked office. Upon completion of the study, all information that matches up individual 
respondents with their answers or fitness test results will be destroyed. 
 
Participation and Withdrawal: 
Your participation is entirely voluntary.  You are free to choose not to participate.  Should you choose to 
participate, you can withdraw at any time without consequences of any kind. 
 
Reporting Procedures: 
Participants will be provided health and fitness tests data at the completion of each test. The findings of the 
study will be presented at regional and national organizations conferences and submitted for publication in 
professional journals 
  
Questions about the Study: 
If you have questions or concerns during the time of your participation in this study, or after its completion 
or you would like to receive a copy of the final aggregate results of this study, please contact: 
 
Dr. Judith A. Flohr, Ph.D 
Department of Kinesiology 
Morrison Bruce Center for the Promotion of Physical Activity for Girls and Women 




Questions about Your Rights as a Research Subject 
Dr. David Cockley  
Chair, Institutional Review Board 





Giving of Consent 
I have read this consent form and I understand what is being requested of me as a participant in this study.  
I freely consent to participate.  I have been given satisfactory answers to my questions.  The investigator 
provided me with a copy of this form.  I certify that I am at least 18 years of age. 
 
My initials below signify that I agree to participate in the test for the phase(s) I have indicated above. 
 
 
____________________________________     
Name of Participant (Printed) 
 
______________________________________    ______________ 
Name of Participant (Signed)                                   Date 
 
____________________________________     
Name of Witness (Printed) 
 
______________________________________    ______________ 






James Madison University 
Department of Kinesiology 
Women Atherosclerosis Inflammation and Thrombosis (WAIAT) 
Health Status Questionnaire 
 
Instructions: Complete each question accurately. All information provided is confidential. 
Part I Demographic Information 
 
1.              
 ID# ______      Date 
 
2.              
 Legal Name       Nickname 
 
3.              
 Mailing Address (Local Address)     Local Phone 
                 
    
 4.              
 Permanent Address (Home)     Phone 
                 
 
5. Gender (circle one)  Male   Female 
 
6. Date of Birth       
   Month/ Day/ Year 
 
Part II Medical History 
7. Circle any that died of heart attack before age 50 Father Mother Brother Sister Grandparent 
 
8. Date of Last medical exam: ________________  Last physical fitness test: _______________ 
 
9. Circle operations you have had: Back Heart Kidney Eyes Joint Neck Ears Hernia  
     
     Lung Other       
 
10. Please circle any of the following for which you have been diagnosed of treated by a physician or 
health professional: 
 
Alcoholism   Diabetes    Kidney problems  
Anemia (sickle cell)  Emphysema   Mental Illness 
Anemia (other)   Epilepsy    Neck Strain 
Asthma    Eye Problems   Obesity 
Back Strain   Gout    Phlebitis 
Bleeding trait   Hearing Loss   Rheumatoid arthritis 
Bronchitis, chronic  Heart Problem   Stroke 
Cancer    High Blood Pressure  Thyroid problem 
Cirrhosis, liver   Hypoglycemia   Ulcer 
Concussion   Hyperlipidemia   Other _______________________ 





11. Circle all medications taken in the last six months: 
Blood thinner   Epilepsy medication  Nitroglycerin 
Diabetic pill   Heart-rhythm medication  Other _______________________ 
Digitalis    High-blood pressure medication 
Diuretic    Insulin 
 
12. Any of these health symptoms that occur frequently is the basis for medical attention. Circle the number 
indicating how often you have each of the following: 
 
5 = Very often 4 = Fairly often 3 = Sometimes 2 = Infrequently 1 = practically never 
 
a. cough up blood  f. chest pain 
    1   2   3   4   5       1   2   3   4   5 
 
b. abdominal pain  g. swollen joints 
    1   2   3   4   5       1   2   3   4   5 
 
c. low back pain   h. feels faint 
    1   2   3   4   5       1   2   3   4   5 
 
d. leg pain   i. Dizziness 
    1   2   3   4   5       1   2   3   4   5 
 
e. arm or shoulder pain  j. breathless on slight exertion 
    1   2   3   4   5       1   2   3   4   5 
 
 
Part III Health Related Behavior 
13. Do you smoke?  Yes  No 
 
14. If you are a smoker, indicate the number smoked per day: 
 
Cigarettes:  40 or more  20-39  10-19  1-9 
Cigars or pipes only: 5 or more or any inhaled  less than 5, none inhaled 
 
15. Do you exercise regularly? Yes  No 
 
16. How many times in a week do you spend at least 20 minutes in moderate to strenuous exercise? 
 
 1 2 3 4 5 6 7 days per week 
 
17. Can you walk 4 miles briskly without fatigue? Yes No 
 
18. Can you jog 3 miles continuously at a moderate pace without discomfort? Yes  No 
 
19. Weight now: __________ lb. One year ago: __________ lb. Age 21: __________ lb. 
 
Source: Howley and Franks. (2007). Health Fitness Instructor’s Handbook. Health Status Questionnaire. 









James Madison University 
Department of Kinesiology 
Women Atherosclerosis Inflammation and Thrombosis (WAIAT) 






James Madison University 
Department of Kinesiology 
Women Atherosclerosis Inflammation and Thrombosis (WAIAT) 
Food Intake Record 
Name:_________________               Date:_______________               Day: 1 2 3 (circle one)               
Notes:_____________________________________________  
Time Location DETAILED Description (Be as detailed 
as possible in describing the food item.  
For example not just chicken, but how 
it’s cooked (fried, grilled, baked, etc), 
and include any sauces or dressings put 
on any food item.  Remember beverages 






     
     
     
     
     
     
     
     
     
     
     
     
     
     




James Madison University 
Department of Kinesiology 
Women Atherosclerosis Inflammation and Thrombosis (WAIAT) 
Maximal Oxygen Consumption Data 
 
Study ID # ___________  Date ___________________ Time of Day 
__________________ 
Height _____(in) _____(cm) Weight _____(lb) _____(kg) Date of Birth 
__________________ 
Age ________________ Resting HR _____________bpm Resting BP 
_______/_______mmHg 














WU 1 2-3  
0% 
 
     
WU 2 2-3    
WU 3 2-3    
WU 4 2-3    
WU 5 2-3    
E 1 3.0 3%     
E 2 3.0    
E3 3.0 6%     
E4 3.0    
E5 3.0 9%     
E6 3.0    
E7 3.0 12%     
E8 3.0    
E9 3.0 15%     
E 10 3.0    
E 11 3.3 15%     
E 12 3.3    
E 13 3.6 15%     
E 14 3.6     
E 15 3.9 15%     
E 16 3.9     
CD 1 3.0  
 
0% 
    
CD 2 3.0    
CD 3 3.0    
CD 4 3.0    
CD 5 3.0    
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